![Sharon Longhurst](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sharon Longhurst
Director/Board Member at
ELICERA THERAPEUTICS AB
Profile
Sharon Longhurst is currently an Independent Director at Idogen AB and Elicera Therapeutics AB. Previously, she worked as the Head-Chemistry, Manufacturing & Control at Mendus AB and as the Vice President-Development at Gadeta BV from 2021 to 2023.
Dr. Longhurst holds a doctorate degree from the University of Warwick and an undergraduate degree from the University of Surrey.
Sharon Longhurst active positions
| Companies | Position | Start |
|---|---|---|
| ELICERA THERAPEUTICS AB | Director/Board Member | 2023-12-31 |
Idogen AB
 Idogen AB BiotechnologyHealth Technology Develops cell therapies for treatment of autoimmune diseases | Director/Board Member | 2020-05-11 |
Former positions of Sharon Longhurst
| Companies | Position | End |
|---|---|---|
Gadeta BV
 Gadeta BV BiotechnologyHealth Technology Conducts research and develops medicines & treatment methods for cancer | Corporate Officer/Principal | 2023-07-31 |
| MENDUS AB | Corporate Officer/Principal | - |
Training of Sharon Longhurst
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
23
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
University of Warwick
 University of Warwick Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Surrey
 University of Surrey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mendus AB
 Mendus AB BiotechnologyHealth Technology Develops immunotherapies for therapeutic treatment of cancer | Health Technology |
Idogen AB
Idogen AB BiotechnologyHealth Technology Develops cell therapies for treatment of autoimmune diseases | Health Technology |
Gadeta BV
Gadeta BV BiotechnologyHealth Technology Conducts research and develops medicines & treatment methods for cancer | Health Technology |
Elicera Therapeutics AB
 Elicera Therapeutics AB BiotechnologyHealth Technology Develops and trades cell and gene therapies in immune-oncology | Health Technology |
- Stock Market
- Insiders
- Sharon Longhurst
